- ETST
is dedicated to meeting the need for high-quality products and devices at
affordable prices
- The
company offers high-purity, top-quality full-spectrum CBD by utilizing
seven cannabinoids that work together synergistically
- ETST
is empowering women with discreet STI testing through its new, low-cost
Hygee medical device kit
Florida-based biotech company Earth Science Tech Inc. (OTCQB: ETST) operates in the
fields of hemp cannabinoids, nutraceuticals, pharmaceuticals, medical devices,
and research and development. The company is passionate about the products that
it offers and is dedicated to providing the highest-quality products and
devices at affordable prices to meet a burgeoning global need.
Not all CBD products are created equal. ETST offers the
highest purity and quality full-spectrum, high-grade cannabinoids on the
market. Utilizing a well-branded product line and strong distribution channels
that include online and retail store sales, the company is able to reach a
large consumer base.
Three of ETST’s wholly owned subsidiaries focus on the
medical, recreational and industrial hemp industries. These include:
- Canna
Inno Laboratories Inc. accesses Canadian government funding for
the advancement of further product research and development; this subsidiary
allows ETST to qualify for grants offered to pharmaceutical innovators.
- Cannabis
Therapeutics Inc. focuses on becoming a leader in the development
of innovative CBD-based nutraceutical and pharmaceutical products.
- KannaBidoid works
within the recreational cannabis space to provide a wide variety of
products.
ETST products are unique in that they offer one of the
highest CBD profiles of any full-spectrum hemp oil on the market. These
exclusive full-spectrum products combine seven cannabinoids (http://ibn.fm/Mu0TJ), rather
than the two to four that are more common in today’s market. All of ETST’s
full-spectrum cannabinoid products contain CBD, CBDa, CBG, CBGa, CBN, CBC and
CBDV, as well as terpenoids, amino acids, omegas, saponins and flavonoids.
These individual elements work together to promote optimal results.
A recent 60-second infomercial (http://ibn.fm/LYTpv) introduces
ETST’s CBD product line. The spot highlights the successful results of case
studies and points viewers to where they can purchase ETST products online or
in local health food stores. Thanks to recent legalizations, the company now
offers products in all 50 states, as well as some 40 countries.
In addition to ETST’s work within the medicinal,
pharmaceutical and hemp industries, the company is bringing to market
cutting-edge pharmaceutical and medical device offerings through wholly owned
subsidiary Earth Science Pharmaceutical Inc. This subsidiary focuses on the
development of low-cost, non-invasive diagnostic tools, testing processes,
medical devices and vaccines for sexually transmitted illnesses.
ETST’s new-to-market medical device, Hygee, was created to
fight sexually transmitted infections (STIs). This self-sampling kit empowers
women with discretion, enabling them to anonymously test for STIs such as
chlamydia.
“No other existing method of collecting genital specimens
from women is more convenient or more efficient than Hygee,” Dr. Michel Aube,
ETST’s CEO and chief science officer, stated in a news release (http://ibn.fm/sUf1T). “Through
intentional design, Hygee is a ‘mistake-proof’ medical device with extremely
simple instructions that allow any woman, regardless of age or education, the
assurance of correctly using the kit on the first try. With roughly 130 million
new chlamydia cases diagnosed yearly, according to the WHO, Hygee is dedicated
to this area of women’s health.”
The combination of strategic partnerships, high-quality
products, a diverse portfolio, solid research and development, and a strong
management team comprised of industry experts positions ETST to experience
rapid growth in multiple markets.
For more information, visit the company’s website at www.EarthScienceTech.com
NOTE TO INVESTORS: The latest news and updates
relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST
About MissionIR
MissionIR is
primarily focused on strategic communications. We have executed countless
communications programs to address the needs of companies ranging from
start-ups to established industry leaders, gaining valuable experience and the
expertise necessary to determine the most effective strategy for any given
situation.
For more information, visit www.MissionIR.com
Please see full terms of use and disclaimers on the Mission
Investor Relations website applicable to all content provided by MIR, wherever
published or re-published: http://www.missionir.com/disclaimer.html
